A, D., F, V., K, M., X, Z., X, R., K, S., . . . BF, B. (2011). The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats. European journal of pharmacology, 650(2-3), 703. https://doi.org/10.1016/j.ejphar.2010.10.062
Chicago Style (17th ed.) CitationA, Duttaroy, Voelker F, Merriam K, Zhang X, Ren X, Subramanian K, Hughes TE, and Burkey BF. "The DPP-4 Inhibitor Vildagliptin Increases Pancreatic Beta Cell Mass in Neonatal Rats." European Journal of Pharmacology 650, no. 2-3 (2011): 703. https://doi.org/10.1016/j.ejphar.2010.10.062.
MLA (9th ed.) CitationA, Duttaroy, et al. "The DPP-4 Inhibitor Vildagliptin Increases Pancreatic Beta Cell Mass in Neonatal Rats." European Journal of Pharmacology, vol. 650, no. 2-3, 2011, p. 703, https://doi.org/10.1016/j.ejphar.2010.10.062.